Day: March 25, 2024

Digerati Technologies Reports Revenue of $7.56 Million for Second Quarter Fiscal Year 2024

Written by Customer Service on March 25, 2024. Posted in Earnings Releases And Operating Results.

– Non-GAAP Adjusted Operating EBITDA Income of $1.267 Million, A Record High as a Percentage of Revenue – – Focused on Increasing the Profitability of Existing Revenue Streams, Increasing the Average Revenue per Customer, and Providing Exceptional Customer Support – SAN ANTONIO, Texas, March 25, 2024 (GLOBE NEWSWIRE) — Digerati Technologies, Inc. (OTCQB: DTGI) (“Digerati” or the “Company”), a provider of cloud services specializing in Unified Communications as a Service (“UCaas”) solutions for the small to medium-sized business (“SMB”) market, announced today financial results for the three and six months ended January 31, 2024, the Company’s second quarter for its Fiscal Year 2024. Key Financial Highlights for the Three Months Ended January 31, 2024 (Compared to Three Months...

Galaxy Gaming Reports Q4 and FY 2023 Financial Results

Written by Customer Service on March 25, 2024. Posted in Earnings Releases And Operating Results.

LAS VEGAS, March 25, 2024 (GLOBE NEWSWIRE) — Galaxy Gaming, Inc. (OTCQB: GLXZ), a developer and distributor of casino table games and enhanced systems for land-based casinos and iGaming content, announced today its financial results for the quarter and year ended December 31, 2023. Financial Highlights Q4 2023 vs. Q4 2022Revenue (gross) increased 25% to $8,382K Revenue (net) increased 13% to $6,737K Net loss of $(820)K vs. net income of $55K Adjusted EBITDA decreased 10% to $2,828KIncreased 10% when adjusting Q4 22 for ERTC1Fiscal Year 2023 vs. Fiscal Year 2022Revenue (gross) increased 23% to $31,729K Revenue (net) increased 19% to $27,789K Net loss of $(1,808)K vs. net loss of $(1,773)K Adjusted EBITDA increased 1% to $10,635KIncreased 7% when adjusting FY 22 for ERTC2Balance Sheet Changes (vs. December 31, 2022)Cash...

BOS’ Intelligent Robotics Division Receives an Order for €565,000

Written by Customer Service on March 25, 2024. Posted in Public Companies.

RISHON LE ZION, Israel, March 25, 2024 (GLOBE NEWSWIRE) — BOS Better Online Solutions Ltd. (“BOS” or the “Company”) (NASDAQ: BOSC) announced today that its Intelligent Robotics Division has received a €565,000 order for a robotic production line from an Israeli defense-industry customer. The order is for delivery in the fourth quarter of 2024. Eyal Cohen, BOS’ CEO, stated: “Our strategic growth plan for the Intelligent Robotics division focuses on customers from the Israeli defense market, which have a great potential for recurring orders. I am pleased with the execution of this strategy that is reflected by this order from an existing customer.” About BOS BOS’ technologies enhance inventory processes through three business divisions:The Intelligent Robotics division automates industrial and logistic inventory processes; The...

Clinical Data on the Impact of Sotagliflozin on Stroke and Heart Attack Risk Among Four Lexicon-Sponsored Presentations at the American College of Cardiology 73rd Annual Scientific Session & Expo

Written by Customer Service on March 25, 2024. Posted in Public Companies.

THE WOODLANDS, Texas, March 25, 2024 (GLOBE NEWSWIRE) — Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) today announced that four data presentations related to sotagliflozin, an inhibitor of two sodium glucose transport proteins (SGLT2 and SGLT1), will be delivered during the American College of Cardiology 73rd Annual Scientific Session & Expo being held April 6 – 8, 2024 in Atlanta, Georgia, including results from a post-hoc evaluation of the efficacy of sotagliflozin in reducing stroke events in patients with type 2 diabetes, chronic kidney disease (CKD), and high cardiovascular (CV) risk in the SCORED Phase 3 clinical trial. “Following FDA’s 2023 approval of INPEFA® (sotagliflozin) for heart failure (HF), researchers are adding to the overall scientific understanding of sotagliflozin, including clinical evidence of its...

Cassava Sciences Announces Completion of an Interim Safety Review of Oral Simufilam On-going Phase 3 Trials

Written by Customer Service on March 25, 2024. Posted in Public Companies.

An Independent Data and Safety Monitoring Board (DSMB) Recently Evaluated the Interim Patient Safety Database for Oral Simufilam in On-going Phase 3 Trials.The DSMB Recommended Both Phase 3 Trials Continue as Planned, Without Modification.Final Clinical Safety Data for Simufilam Are Expected at the Conclusion of the Phase 3 Program.AUSTIN, Texas, March 25, 2024 (GLOBE NEWSWIRE) — Cassava Sciences, Inc. (Nasdaq: SAVA), a biotechnology company focused on Alzheimer’s disease, today announced the completion of another interim safety review of simufilam in on-going Phase 3 clinical trials in patients with Alzheimer’s disease. A routine, scheduled meeting of a Data and Safety Monitoring Board (DSMB) recommended that both of Cassava Sciences’ on-going Phase 3 studies continue as planned, without modification. “This interim safety...

Atlantica Announces the Acquisition of Two Wind Assets in the United Kingdom

Written by Customer Service on March 25, 2024. Posted in Mergers And Acquisitions.

Atlantica Announces the Acquisition of Two Wind Assets in the United Kingdom March 25, 2024 – Atlantica Sustainable Infrastructure plc (NASDAQ: AY) (“Atlantica” or the “Company”), announced today that it completed the acquisition of a 100% equity interest stake in two wind assets, with a combined installed capacity of 32 MW in Scotland, United Kingdom. The assets are regulated under the UK green attribute regulation and are granted renewables obligation certificates until 2033. They have demonstrated a solid operating track record and currently do not have any project debt. The acquisition closed on March 22, 2024, and Atlantica’s investment amount was approximately $66 million. The purchase price represents an Enterprise Value1/EBITDA2 multiple of approximately 6.6 times. These are Atlantica’s first operating assets in the U.K., and the...

Form 8.3 – ish Residential Properties REIT plc

Written by Customer Service on March 25, 2024. Posted in Mergers And Acquisitions.

FORM 8.3 IRISH TAKEOVER PANEL DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013 DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE 1. KEY INFORMATIONName of person dealing (Note 1) State Street Global Advisors & AffiliatesCompany dealt in Irish Residential Properties REIT plcClass of relevant security to which the dealings being disclosed relate (Note 2) €0.10 ordinary sharesDate of dealing 22 March 20242. INTERESTS AND SHORT POSITIONS (110) Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3) Long Short Number (%) Number (%)(1) Relevant securities 9,859,967 1.86185% (2) Derivatives (other than options) N/A N/A (3) Options...

Gabelli Multimedia Trust Appoints Susan Watson Laughlin to the Board of Trustees

Written by Customer Service on March 25, 2024. Posted in Public Companies.

RYE, N.Y., March 25, 2024 (GLOBE NEWSWIRE) — The Board of Directors of The Gabelli Multimedia Trust Inc. (the “Board”) (NYSE: GGT) (the “Fund”) announced the appointment of Susan Watson Laughlin to the Board of the Fund effective February 13, 2024. Ms. Watson Laughlin brings to the Board an extensive career in investor relations with such notable firms as MCI, Interpublic Group, Pepsico, Nielsen Media Research, Gannett and Metromedia. Most recently, she served in the Board of Directors Practice at Spencer Stuart. She began her career as an analyst with Scudder Stevens & Clark and was subsequently a Senior Media Analyst at EF Hutton and Morgan Stanley. She has been a Chartered Financial Analyst since 1980. Ms. Watson Laughlin holds a B.A. in Economics from the University of Southern California and an M.A. in Education from...

N2OFF: Save Foods Increasing its Potential Market Reach Following Pre-Harvest Regulatory Approval in California

Written by Customer Service on March 25, 2024. Posted in Public Companies.

Company is now poised to offer its solution in California targeting the $14 billion market of organic products Neve Yarak, Israel, March 25, 2024 (GLOBE NEWSWIRE) — N2OFF, Inc. (NASDAQ: NITO) (FSE:80W) (“N2OFF” or the “Company”), a pioneer agri-food tech company offering sustainable solutions for agriculture and plant-based food, previously announced that the California Department of Pesticide Regulation (CDPR) registered for use Save Foods Ltd.’s pre-harvest treatment, FieldProtect, based on its compliance with California laws and regulations pertaining to pesticide registration. The approval now extends the use of the product in California from exclusively post-harvest processes to include pre-harvest applications, which significantly broadens Save Foods’ potential market reach. We believe this marks an important step...

Alpha Tau to Present at the Jefferies Radiopharma Innovation Summit

Written by Customer Service on March 25, 2024. Posted in Public Companies.

JERUSALEM, March 25, 2024 (GLOBE NEWSWIRE) — Alpha Tau Medical Ltd. (“Alpha Tau”, or the “Company”) (NASDAQ: DRTS, DRTSW), the developer of the innovative alpha-radiation cancer therapy Alpha DaRT™, today announced that CFO Raphi Levy will present a corporate overview and update at the Jefferies Radiopharma Innovation Summit on April 11th, 2024.Event: Jefferies Radiopharma Innovation SummitDate: April 11, 2024Time: 12:40-1:10 PM ESTLocation: New York, NYMr. Levy will also be available for 1×1 investor meetings at the conference. Please reach out to your Jefferies representative to schedule. About Alpha Tau Medical Ltd. Founded in 2016, Alpha Tau is an Israeli medical device company that focuses on research, development, and potential commercialization of the Alpha DaRT for the treatment of...

Day: March 25, 2024

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Cookie Notice